Table 3 Association of CAD and acute myocardial infarction (AMI) with inflammatory parameters.

From: The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis

Inflammatory markers

CAD+ AMI-

CAD+ AMI+

ATS

Unadjusted B(SE)

P-value

Adjusted B(SE) #&

P-value

Unadjusted B(SE)

P-value

Adjusted B(SE) #&

P-value

B(SE)

P-value

AdjustedB(SE) #$

P-value

C-reactive protein

1.08 (0.52)

0.038

1.04 (0.60)

0.087

1.41 (0.57)

0.038

1.24 (0.62)

0.040

0.61 (0.61)

0.315

0.49 (0.68)

0.466

WBC

0.19 (0.33)

0.567

0.22 (0.38)

0.563

-0.17 (0.41)

0.670

-0.00(0.44)

0.993

0.12 (0.43)

0.783

0.12 (0.49)

0.801

NL ratio

0.03 (0.19)

0.891

-0.16 (0.21)

0.452

0.20 (0.23)

0.387

0.22 (0.23)

0.346

0.56 (0.24)

0.018

0.40 (0.26)

0.127

  1. ATS: Atherothrombotic stroke, CAD + AMI + : Coronary artery disease with history of Acute myocardial infarction; CAD + AMI-: Coronary artery disease without history of Acute myocardial infarction, B: Regression co-efficient, SE: Standard error.
  2. #Adjusted for age, gender, body mass index (BMI), diabetes mellitus (DM), hypertension (HTN), cancer, chronic kidney disease (stage 3–5), asthma, chronic obstructive pulmonary disease (COPD), liver cirrhosis, transplant status, baseline sputum AFB status, cavitary disease at baseline, metformin use, statin use, and calcium channel blocker use.
  3. &Additionally adjusted for ATS.
  4. $Additionally adjusted for CAD.
Back to article page